Microarray technology reveals potentially novel genes and pathways involved in non-functioning pituitary adenomas

Qiao, X; Wang, H; Wang, X; Zhao, B; Liu, J

doi:10.1515/bjmg-2016-0030

Abstract

Microarray data of non-functioning pituitary adenomas (NFPAs) were analyzed to disclose novel genes and pathways involved in NFPA tumorigenesis. Raw microarray data were downloaded from Gene Expression Omnibus. Data pre-treatment and differential analysis were conducted using packages in R. Functional and pathway enrichment analyses were performed using package GOs-tats. A protein-protein interaction (PPI) network was constructed using server STRING and Cytoscape. Known genes involved in pituitary adenomas (PAs), were obtained from the Comparative Toxicogenomics Database. A total of 604 differentially expressed genes (DEGs) were identifed between NFPAs and controls, including 177 up- and 427 down-regulated genes. Jak-STAT and p53 signaling pathways were significantly enriched by DEGs. The PPI network of DEGs was constructed, containing 99 up- and 288 down-regulated known disease genes (e.g. EGFR and ESR1) as well as 16 up- and 17 down-regulated potential novel NFPAs-related genes (e.g. COL4A5, LHX3, MSN, and GHSR). Genes like COL4A5, LHX3, MSN, and GHSR and pathways such as p53 signaling and Jak-STAT signaling, might participate in NFPA development. Although further validations are required, these findings might provide guidance for future basic and therapy researches.

References

Gruppetta M, Mercieca C, Vassallo J. Prevalence and incidence of pituitary adenomas: A population based study in Malta. Pituitary. 2013; 16(4): 545-553.
Search in Google Scholar Back to article
Karavitaki N. Prevalence and incidence of pituitary adenomas. Ann Endocrinol (Paris). 2012; 73(2): 79-80.
Search in Google Scholar Back to article
Pereira AM, Biermasz NR. Treatment of non-functioning pituitary adenomas: What were the contributions of the last 10 years? A critical view. Ann Endocrinol (Paris). 2012; 73(2): 111-116.
Search in Google Scholar Back to article
Chaidarun SS, Klibanski A. Gonadotropinomas. Semin Reprod Med. 2002; 20(4): 339-348.
Search in Google Scholar Back to article
Lee M, Marinoni I, Irmler M, Psaras T, Honegger JB, Beschorner R, et al. Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas. Acta Neuropathol. 2013; 126(1): 137-150.
Search in Google Scholar Back to article
Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev. 2013; 34(2): 239-277.
Search in Google Scholar Back to article
Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet. 2010; 78(5): 457-463.
Search in Google Scholar Back to article
Trovato M, Torre ML, Ragonese M, Simone A, Scarf R, Barresi V, et al. HGF/c-met system targeting PI3K/ AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: An immunohistochemical characterization in view of targeted therapies. Endocrine. 2013; 44(3): 735-743.
Search in Google Scholar Back to article
Duran-Prado M, Saveanu A, Luque RM, Gahete MD, Gracia-Navarro F, Jaquet P, et al. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs. J Clin Endocrinol Metab. 2010; 95(5): 2497-2502.
Search in Google Scholar Back to article
Rubinfeld H, Shimon I. PI3K/Akt/mTOR and Raf/ MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas. Endocrine. 2012; 42(2): 285-291.
Search in Google Scholar Back to article
Rotondi S, Oliva MA, Esposito V, Ventura L, Giangaspero F, Alesse E, et al. AIP expression in non-functioning pituitary adenomas is strongly associated with the gonadotroph phenotype but not with tumour aggressiveness. Endocrine Abstracts. 2014; 35: P835. (hppt:// www.endocrine-abstracts.org/ea/0035/ea0035P835/ htm).
Search in Google Scholar Back to article
Mussnich P, Raverot G, Jaffrain-Rea ML, Fraggetta F, Wierinckx A, Trouillas J, et al. Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors. Cell Cycle. 2015; 14(16): 2590-2597.
Search in Google Scholar Back to article
Chesnokova V, Zonis S, Wawrowsky K, Tani Y, Ben-Shlomo A, Ljubimov V, et al. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth. Mol Endocrinol. 2012; 26(12): 2092-2103.
Search in Google Scholar Back to article
Michaelis KA, Knox AJ, Xu M, Kiseljak-Vassiliades K, Edwards MG, Geraci M, et al. Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology. 2011; 152(10): 3603-3613.
Search in Google Scholar Back to article
Cai T, Xiao J, Wang ZF, Liu Q, Wu H, Qiu YZ. Identification of differentially coexpressed genes in gona-dotrope tumors and normal pituitary using bioinformatics methods. Pathol Oncol Res. 2014; 20(2): 375-380.
Search in Google Scholar Back to article
Zhao P, Hu W, Wang H, Yu S, Li C, Bai J, et al. Identification of differentially expressed genes in pituitary adenomas by integrating analysis of microarray data. Int J Endocrinol. 2015; 2015: 164087. doi: 10.1155/2015/ 164087.
Open DOI Search in Google Scholar Back to article
Gautier L, Cope L, Bolstad BM, Irizarry RA. affy— analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004; 20(3): 307-315.
Search in Google Scholar Back to article
Wilson CL, Miller CJ. Simpleaffy: A BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics. 2005; 21(18): 3683-3685.
Search in Google Scholar Back to article
Kolde R. Pheatmap: Pretty Heatmaps. R Package Version 0.7. 7. CRAN Repository, 2012.
Search in Google Scholar Back to article
Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007; 23(2): 257-258.
Search in Google Scholar Back to article
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015; 43(Database issue): D447-D452.
Search in Google Scholar Back to article
Kohl M, Wiese S, Warscheid B. Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol. 2011; 696: 291-303.
Search in Google Scholar Back to article
Davis AP, Grondin CJ, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, et al. The Comparative Toxicogenomics Database’s 10th year anniversary: Update 2015. Nucleic Acids Res. 2015; 43(Database issue): D914-D920.
Search in Google Scholar Back to article
Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R, et al. Mdm2 and the p53 pathway in human pituitary adenomas. Clin Endocrinol (Oxf). 2001; 54(3): 317-325.
Search in Google Scholar Back to article
Butz H, Likó I, Czirják S, Igaz P, Korbonits M, Rácz K, et al. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary. 2011; 14(2): 112-124.
Search in Google Scholar Back to article
Rishi A, Sharma MC, Sarkar C, Jain D, Singh M, Ma-hapatra AK, et al. A clinicopathological and immu-no-histochemical study of clinically non-functioning pituitary adenomas: A single institutional experience. Neurol India. 2010; 58(3): 418-423.
Search in Google Scholar Back to article
Chaidarun SS, Eggo MC, Sheppard MC, Stewart PM. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. Endocrinology. 1994; 135(5): 2012-2021.
Search in Google Scholar Back to article
Onguru O, Scheithauer BW, Kovacs K, Vidal S, Jin L, Zhang S, et al. Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. Mod Pathol. 2004; 17(7): 772-780.
Search in Google Scholar Back to article
Chaidarun SS, Klibanski A, Alexander JM. Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab. 1997; 82(4): 1058-1065.
Search in Google Scholar Back to article
Cheunsuchon P, Zhou Y, Zhang X, Lee H, Chen W, Nakayama Y, et al. Silencing of the imprinted DLK1-MEG3 locus in human clinically non-functioning pituitary adenomas. Am J Pathol. 2011; 179(4): 2120-2130.
Search in Google Scholar Back to article
Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profling and proteomic analyses. Cancer Res. 2005; 65(22): 10214-10222.
Search in Google Scholar Back to article
Simpson DJ, Bicknell JE, McNicol AM, Clayton RN, Farrell WE. Hypermethylation of the p16/CDKN2A/ MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chromosomes Cancer. 1999; 24(4): 328-336.
Search in Google Scholar Back to article
Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T. Ghrelin and growth hormone (GH) secre-tagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clin Endocrinol (Oxf). 2001; 54(6): 759-768.
Search in Google Scholar Back to article
Heim MH. The Jak-STAT pathway: Cytokine signalling from the receptor to the nucleus. J Recept Sig Transd. 1999; 19(1-4): 75-120.
Search in Google Scholar Back to article
Schindler CW. Series introduction: JAK-STAT signaling in human disease. J Clin Invest. 2002; 109(9): 1133-1137.
Search in Google Scholar Back to article
Gong J, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Lopes MBS, et al. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary. 2008; 11(1): 37-48.
Search in Google Scholar Back to article
Paez-Pereda M, Kuchenbauer F, Arzt E, Stalla G. Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. Braz J Med Biol Res. 2005; 38(10): 1487-1494.
Search in Google Scholar Back to article

Microarray technology reveals potentially novel genes and pathways involved in non-functioning pituitary adenomas

Abstract

Paradigm

My account